Medscape |
Oral Basal Insulin Shows Promise in Type 2 Diabetes
Medscape SAN DIEGO — An oral basal insulin formulation has produced glycemic control equivalent to that of injected insulin glargine in insulin-naïve type 2 diabetes patients. Results from a phase 2a Novo Nordisk–sponsored feasibility study were presented on ... |
Social Plugin